In one study, it was reported that treatment using curcumin with cisplatin, which is a platinum-group drug, increased the rate of apoptosis of bladder cancer cells by triggering ROS production and upregulating the p-ERK1/2 and caspase-3 activation [50]. This evidence concerns the gene CASP3 and urinary bladder carcinoma.